Mr. Gaurav Goel, Head-Western Europe at SMT said “We believe ultrathin 60-micron struts, bio-degradable polymer and proven anti proliferative drug are the intrinsic elements to superior performance of ...
The trial was presented in the PCI Outcomes III session in San Francisco. 1835 patients were studied across 19 study centres in UK SMT (Sahajanand Medical Technologies), a pioneering healthcare ...
SMT (Sahajanand Medical Technologies Pvt. Ltd.), India's largest manufacturer of cardiovascular medical stents, today announced the successful results of S flex UK Registry. The one-year outcome data ...
Mumbai / London, UK, 27th January 2018 – SMT (Sahajanand Medical Technologies Pvt. Ltd.) today announced the successful results of S flex UK Registry. The one-year outcome data of the study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback